Abstract
Abstract Viral quantification serves as a valid biomarker for detecting Influenza A infection however viral burden is not closely associated with disease severity or clinical outcomes. Biomarkers reflecting the status of the host immune response are needed to monitor and/or predict disease outcomes in a hospitalized setting. Here, we utilized a sub-lethal mouse model of Influenza A infection to explore plasma and airway cytokines, plasma surfactant proteins (SP-D, SP-A and CC16), and airway bioactive lipid mediators as potential biomarkers of lung leakage and host response, respectively. This study aimed to assess the pharmacodynamic response of these biomarkers after treatment with an efficacious dose of an anti-HA stalk-binding antibody and to assess association of these biomarkers with disease severity metrics. Plasma SP-D and IP-10 correlated with lung viral titers while SP-A and CC16 tracked more closely with changes in bronchial albumin levels and body weight. Bioactive lipid precursors Arachidonic Acid (AA), Docosahexaenoicacid (DHA) and Eicosapentaenoic acid (EPA), reported to have both pro- and anti-inflammatory properties, increase in the lung with infection. 17-HDHA, a DHA metabolite reported to be pro-resolving, was induced later during disease resolution. With anti-HA antibody treatment, all plasma surfactant proteins and precursor lipids in the airway were reduced and 17-HDHA production was accelerated. In summary, plasma SP-D may serve as an early biomarker of host response and/or potentially indicate a decline in lung epithelium integrity. Plasma SP-A, CC16, and pro-inflammatory lipid mediators such as AA may reflect the ongoing host response and may therefore be more closely associated with disease outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.